Skip to main content
Previous
Poster Home
Next
Real-World Clinical Outcomes of First-Line Therapies and Treatment Regimens for BRAF-Mutant Advanced/Metastatic Melanoma: Retrospective Observational Study
07:30am - 03:35pm EST - April 5, 2024
Information
Resources
Abstract: JNCCN23-0661
https://jnccn.org/view/journal...
Author(s):
Ruixuan Jiang, PharmD, PhD
, Merck & Co Inc.
Tags:
Outcomes and Health Services Research
Display Label
Action